CLVT
CLARIVATE PLC
Company overview
- Market capitalization
- $1.09B
- Employees
- 12,000
- Latest publication
- 2026-09-29
About CLARIVATE PLC
Clarivate Plc provides information services in the Americas, the Middle East, Africa, Europe, and the Asia Pacific. It operates through three segments: Academia & Government, Intellectual Property, and Life Sciences & Healthcare. The company offers scientific and academic research solutions; Web of Science Research Intelligence, an AI-native solution; ProQuest solutions to access multidisciplinary curated content, such as databases, dissertations, news, primary sources, books, and video formats; library software, including Alma, library services platform; and Vega and Polaris for public libraries. It also provides patent maintenance and administrative services; Derwent Innovation, an AI-powered search; Derwent World Patents Index to identify related concepts in patent publications and navigate new or unfamiliar technology categories; CompuMark, a trademark search and watch solutions; IP Recordals managed services; and RiskMark, an AI-powered tool for evaluating trademark risk and argument drafting support. In addition, the company offers IPfolio, a management platform; FoundationIP solution for law firms; Cortellis for decisions related to assessing the market, analyzing competitors, regulatory compliance, and drug safety; Regulatory Intelligence platform; commercial solutions; and Medtech solutions. It serves academic institutions, government agencies, and life sciences, and pharmaceutical companies. The company was formerly known as Clarivate Analytics Plc and changed its name to Clarivate Plc in May 2020. Clarivate Plc was founded in 1864 and is headquartered in London, the United Kingdom.
Financial statements
Income Quarterly
| Metric | Q2 20262026-06-30 · USD | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q3 20242024-09-30 · USD | Q1 20242024-03-31 · USD | Q4 20232023-12-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 587,300,000USD | 585,500,000USD | 617,000,000USD | 623,100,000USD | 621,400,000USD | 622,200,000USD | 621,200,000USD | 683,700,000USD |
| Cost Of Revenue | 185,500,000USD | 192,100,000USD | 204,800,000USD | 218,200,000USD | 203,600,000USD | 210,100,000USD | 217,800,000USD | 412,400,000USD |
| Gross Profit | 401,800,000USD | 393,400,000USD | 412,200,000USD | 404,900,000USD | 417,800,000USD | 412,100,000USD | 403,400,000USD | 271,300,000USD |
| Selling General Administrative | 181,600,000USD | 176,300,000USD | 179,100,000USD | 170,000,000USD | 181,100,000USD | 169,700,000USD | 191,900,000USD | 180,400,000USD |
| Total Operating Expenses | 602,000,000USD | 363,200,000USD | 370,800,000USD | 360,900,000USD | 410,900,000USD | 390,400,000USD | 398,400,000USD | 180,400,000USD |
| Operating Income | -200,200,000USD | 30,200,000USD | 41,400,000USD | 44,000,000USD | 6,900,000USD | 21,700,000USD | 5,000,000USD | 90,900,000USD |
| Total Other Income Expense Net | -60,400,000USD | -59,000,000USD | -66,000,000USD | -68,500,000USD | -66,600,000USD | -72,200,000USD | -65,000,000USD | -952,800,000USD |
| Depreciation And Amortization | 185,700,000USD | 184,000,000USD | 189,100,000USD | 191,800,000USD | 190,900,000USD | 177,200,000USD | 179,400,000USD | 180,800,000USD |
| Income Before Tax | -260,600,000USD | -28,800,000USD | -24,600,000USD | -24,500,000USD | -59,700,000USD | -50,500,000USD | -60,000,000USD | -861,900,000USD |
| Income Tax Expense | 8,000,000USD | 11,400,000USD | -27,700,000USD | 3,800,000USD | 12,300,000USD | 15,100,000USD | 15,000,000USD | -18,000,000USD |
| Net Income | -268,600,000USD | -40,200,000USD | 3,100,000USD | -28,300,000USD | -72,000,000USD | -65,600,000USD | -75,000,000USD | -843,900,000USD |
| Unclassified Operating Expenses | — | 186,900,000USD | 191,700,000USD | 190,900,000USD | 229,800,000USD | 220,700,000USD | 206,500,000USD | — |
| Interest Expense | — | 59,000,000USD | 66,000,000USD | 68,500,000USD | 66,600,000USD | 72,200,000USD | 70,200,000USD | 75,200,000USD |
| Net Interest Income | — | -59,000,000USD | -66,000,000USD | -68,500,000USD | -66,600,000USD | -72,200,000USD | -70,200,000USD | -75,200,000USD |
| Tax Provision | — | 11,400,000USD | -27,700,000USD | 3,800,000USD | 12,300,000USD | 15,100,000USD | 15,000,000USD | -18,000,000USD |
| Net Income From Continuing Ops | — | -40,200,000USD | 3,100,000USD | -28,300,000USD | -72,000,000USD | -65,600,000USD | -75,000,000USD | -843,900,000USD |
| Ebit | — | 29,600,000USD | 41,400,000USD | 44,700,000USD | 57,000,000USD | 21,700,000USD | 10,200,000USD | -786,700,000USD |
| Ebitda | — | 213,600,000USD | 230,500,000USD | 236,500,000USD | 247,900,000USD | 198,900,000USD | 189,600,000USD | -605,900,000USD |
| Reconciled Depreciation | — | 184,000,000USD | 189,100,000USD | 191,800,000USD | 190,900,000USD | 177,200,000USD | 179,400,000USD | 180,800,000USD |
| Source | DisclosureDeterministicFinal | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Income Yearly
| Metric | FY 20252025-12-31 · USD | FY 20222022-12-31 · USD | FY 20162016-12-31 · USD | FY 20152015-12-31 · USD | FY 20142014-12-31 · USD |
|---|---|---|---|---|---|
| Total Revenue | 2,455,200,000USD | 2,659,800,000USD | 514,246,000USD | 535,004,000USD | 555,103,000USD |
| Cost Of Revenue | 833,600,000USD | 954,000,000USD | 346,398,000USD | 343,522,000USD | 363,014,000USD |
| Gross Profit | 1,621,600,000USD | 1,705,800,000USD | 167,848,000USD | 191,482,000USD | 192,089,000USD |
| Selling General Administrative | 708,600,000USD | 729,900,000USD | 99,815,000USD | 84,810,000USD | 80,860,000USD |
| Unclassified Operating Expenses | 841,500,000USD | 385,700,000USD | -105,256,000USD | -91,235,000USD | — |
| Total Operating Expenses | 1,550,100,000USD | 1,115,600,000USD | 0USD | 0USD | 117,484,000USD |
| Operating Income | 71,500,000USD | -3,925,600,000USD | 24,522,000USD | 64,794,000USD | 74,605,000USD |
| Interest Expense | 265,399,999USD | 270,300,000USD | 0USD | 0USD | 0USD |
| Net Interest Income | -265,400,000USD | -270,300,000USD | — | — | — |
| Income Before Tax | -193,900,000USD | -3,989,100,000USD | 20,073,000USD | 63,386,000USD | 72,508,000USD |
| Income Tax Expense | 7,200,000USD | -28,900,000USD | 6,276,000USD | 19,923,000USD | 23,138,000USD |
| Tax Provision | 7,200,000USD | -28,900,000USD | — | — | — |
| Net Income | -201,100,000USD | -3,960,200,000USD | 13,797,000USD | 43,463,000USD | 49,370,000USD |
| Net Income From Continuing Ops | -201,100,000USD | -3,960,200,000USD | 13,797,000USD | 43,463,000USD | 49,370,000USD |
| Ebit | 172,100,000USD | 590,200,000USD | 22,458,000USD | 64,159,000USD | 72,771,000USD |
| Ebitda | 929,300,000USD | 1,300,700,000USD | — | — | — |
| Depreciation And Amortization | 757,200,000USD | 710,500,000USD | — | — | — |
| Reconciled Depreciation | 757,200,000USD | 710,500,000USD | — | — | — |
| Total Other Income Expense Net | -265,400,000USD | -4,309,000,000USD | -2,064,000USD | -635,000USD | -1,834,000USD |
| Non Operating Income Net Other | — | 206,800,000USD | — | — | — |
| Net Income Applicable To Common Shares | — | -4,035,600,000USD | 13,797,000USD | 43,463,000USD | 49,370,000USD |
| Research Development | — | — | 5,441,000USD | 6,425,000USD | 6,406,000USD |
| Other Operating Expenses | — | — | — | — | 30,470,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Quarterly
| Metric | Q2 20262026-06-30 · USD | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Assets | 10,486,100,000USD | 10,927,100,000USD | 11,069,400,000USD | 11,227,600,000USD | 11,421,200,000USD | 11,492,700,000USD | 11,490,200,000USD | 12,030,600,000USD |
| Cash And Equivalents | 217,700,000USD | — | — | — | — | — | — | — |
| Total Current Assets | 1,214,200,000USD | 1,301,100,000USD | 1,310,000,000USD | 1,291,100,000USD | 1,340,200,000USD | 1,354,300,000USD | 1,244,600,000USD | 1,339,100,000USD |
| Other Current Assets | 61,500,000USD | 185,900,000USD | 159,100,000USD | 161,700,000USD | 157,200,000USD | 169,800,000USD | 151,100,000USD | 178,800,000USD |
| Other Non Current Assets | 86,500,000USD | — | — | — | — | — | — | — |
| Total Liabilities | 5,948,600,000USD | — | — | — | — | — | — | — |
| Total Current Liabilities | 1,435,700,000USD | 1,542,100,000USD | 1,568,800,000USD | 1,489,600,000USD | 1,478,800,000USD | 1,540,600,000USD | 1,433,500,000USD | 1,525,600,000USD |
| Other Non Current Liabilities | 75,800,000USD | — | — | — | — | — | — | — |
| Total Stockholder Equity | 4,537,500,000USD | 4,788,800,000USD | 4,842,900,000USD | 4,903,800,000USD | 4,994,100,000USD | 5,027,100,000USD | 5,139,000,000USD | 5,513,500,000USD |
| Total Equity Including Noncontrolling Interest | 4,537,500,000USD | — | — | — | — | — | — | — |
| Long Term Debt | 4,209,300,000USD | 4,281,600,000USD | 4,321,500,000USD | 4,419,000,000USD | 4,516,800,000USD | 4,521,100,000USD | 4,518,700,000USD | 4,632,500,000USD |
| Deferred Revenue | 897,000,000USD | — | — | — | — | — | — | — |
| Net Receivables | 827,900,000USD | 882,900,000USD | 821,700,000USD | 810,700,000USD | 820,400,000USD | 830,500,000USD | 798,300,000USD | 771,800,000USD |
| Property Plant Equipment Net | 88,300,000USD | 93,400,000USD | 99,300,000USD | 102,600,000USD | 109,500,000USD | 110,400,000USD | 107,100,000USD | 105,400,000USD |
| Goodwill | 1,344,900,000USD | — | — | — | — | — | — | — |
| Intangible Assets | 7,734,300,000USD | 7,863,700,000USD | 8,008,100,000USD | 8,149,000,000USD | 8,284,000,000USD | 8,341,400,000USD | 8,441,200,000USD | 8,726,700,000USD |
| Accounts Payable | 152,900,000USD | 135,700,000USD | 150,600,000USD | 139,700,000USD | 125,700,000USD | 120,000,000USD | 124,500,000USD | 126,500,000USD |
| Short Term Debt | 16,700,000USD | 19,100,000USD | 119,900,000USD | 37,400,000USD | 40,200,000USD | 42,000,000USD | 41,200,000USD | 44,200,000USD |
| Common Stock | 12,815,200,000USD | 12,801,300,000USD | 12,810,600,000USD | 12,867,900,000USD | 12,902,700,000USD | 12,935,100,000USD | 12,978,800,000USD | 13,069,000,000USD |
| Retained Earnings | -7,823,400,000USD | -7,554,800,000USD | -7,514,600,000USD | -7,517,700,000USD | -7,489,400,000USD | -7,417,400,000USD | -7,313,500,000USD | -7,121,700,000USD |
| Accumulated Other Comprehensive Income | -454,300,000USD | -457,700,000USD | -453,100,000USD | -446,400,000USD | -419,200,000USD | -490,600,000USD | -526,300,000USD | -433,800,000USD |
| Total Liab | — | 6,138,300,000USD | 6,226,500,000USD | 6,323,800,000USD | 6,427,100,000USD | 6,465,600,000USD | 6,351,200,000USD | 6,517,100,000USD |
| Other Current Liab | — | 386,900,000USD | 356,900,000USD | 439,700,000USD | 383,800,000USD | 399,800,000USD | 408,700,000USD | 464,700,000USD |
| Capital Stock | — | 12,801,300,000USD | 12,810,600,000USD | 12,867,900,000USD | 12,902,700,000USD | 12,935,100,000USD | 12,978,800,000USD | 13,069,000,000USD |
| Good Will | — | 1,566,600,000USD | 1,566,700,000USD | 1,566,700,000USD | 1,566,900,000USD | 1,566,600,000USD | 1,566,600,000USD | 1,736,800,000USD |
| Cash | — | 232,300,000USD | 329,200,000USD | 318,700,000USD | 362,600,000USD | 354,000,000USD | 295,200,000USD | 388,500,000USD |
| Cash And Short Term Investments | — | 232,300,000USD | 329,200,000USD | 318,700,000USD | 362,600,000USD | 354,000,000USD | 295,200,000USD | 388,500,000USD |
| Current Deferred Revenue | — | 1,000,400,000USD | 941,400,000USD | 872,800,000USD | 929,100,000USD | 978,800,000USD | 859,100,000USD | 890,200,000USD |
| Net Debt | — | 4,102,100,000USD | 4,150,100,000USD | 4,161,100,000USD | 4,224,100,000USD | 4,241,300,000USD | 4,297,300,000USD | 4,324,000,000USD |
| Short Long Term Debt | — | 1,500,000USD | 101,500,000USD | — | — | — | 1,300,000USD | — |
| Short Long Term Debt Total | — | 4,334,400,000USD | 4,479,300,000USD | 4,479,800,000USD | 4,586,700,000USD | 4,595,300,000USD | 4,592,500,000USD | 4,712,500,000USD |
| Property Plant Equipment Gross | — | 93,400,000USD | 199,700,000USD | 102,600,000USD | 109,500,000USD | 110,400,000USD | 196,300,000USD | 105,400,000USD |
| Common Stock Shares Outstanding | — | 640,700,000shares | 662,300,000shares | 668,300,000shares | 681,300,000shares | 689,800,000shares | 702,800,000shares | 718,700,000shares |
| Non Current Assets Total | — | 9,626,000,000USD | 9,759,400,000USD | 9,936,500,000USD | 10,081,000,000USD | 10,138,400,000USD | 10,245,600,000USD | 10,691,500,000USD |
| Non Current Liabilities Total | — | 4,596,200,000USD | 4,657,700,000USD | 4,834,200,000USD | 4,948,300,000USD | 4,925,000,000USD | 4,917,700,000USD | 4,991,500,000USD |
| Non Current Liabilities Other | — | 75,900,000USD | 86,200,000USD | 98,600,000USD | 97,400,000USD | 74,900,000USD | 55,900,000USD | 52,500,000USD |
| Non Currrent Assets Other | — | 71,700,000USD | 66,300,000USD | 63,100,000USD | 62,400,000USD | 61,800,000USD | 67,500,000USD | 64,400,000USD |
| Net Working Capital | — | -241,000,000USD | -258,800,000USD | -198,500,000USD | -138,600,000USD | -186,300,000USD | -188,900,000USD | -186,500,000USD |
| Unclassified Non Current Liabilities | — | 238,700,000USD | 250,000,000USD | 316,600,000USD | 334,100,000USD | 329,000,000USD | 343,100,000USD | 306,500,000USD |
| Unclassified Equity | — | -12,801,300,000USD | -12,810,600,000USD | -12,867,900,000USD | -12,902,700,000USD | -12,935,100,000USD | -12,978,800,000USD | -13,069,000,000USD |
| Unclassified Current Liabilities | — | — | -101,500,000USD | — | — | — | — | — |
| Source | DisclosureDeterministicFinal | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD | FY 20182018-12-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Assets | 11,069,400,000USD | 11,490,200,000USD | 12,706,800,000USD | 13,944,900,000USD | 20,182,979,000USD | 15,197,344,000USD | 3,791,371,000USD | 3,709,674,000USD |
| Intangible Assets | 8,008,100,000USD | 8,441,200,000USD | 9,006,600,000USD | 9,437,700,000USD | 10,392,354,000USD | 7,370,350,000USD | 1,828,640,000USD | 1,958,520,000USD |
| Other Current Assets | 159,100,000USD | 151,100,000USD | 183,200,000USD | 76,900,000USD | 143,197,000USD | 318,829,000USD | 83,088,000USD | 51,742,000USD |
| Total Liab | 6,226,500,000USD | 6,351,200,000USD | 6,714,500,000USD | 7,132,400,000USD | 8,257,110,000USD | 5,603,373,000USD | 2,542,772,000USD | 2,659,067,000USD |
| Total Stockholder Equity | 4,842,900,000USD | 5,139,000,000USD | 5,992,300,000USD | 6,812,500,000USD | 11,925,869,000USD | 9,593,971,000USD | 1,248,599,000USD | 1,050,607,000USD |
| Other Current Liab | 356,900,000USD | 322,600,000USD | 448,400,000USD | 484,200,000USD | 651,065,001USD | 742,773,000USD | 179,091,000USD | 153,849,000USD |
| Common Stock | 12,810,600,000USD | 12,978,800,000USD | 11,740,500,000USD | 11,744,700,000USD | 11,827,915,000USD | 10,049,317,000USD | 2,144,372,000USD | 16,000USD |
| Capital Stock | 12,810,600,000USD | 12,978,800,000USD | 13,133,100,000USD | 13,137,300,000USD | 13,220,531,000USD | 10,049,317,000USD | 2,208,529,000USD | 16,000USD |
| Retained Earnings | -7,514,600,000USD | -7,313,500,000USD | -6,645,500,000USD | -5,658,900,000USD | -1,604,461,000USD | -958,867,000USD | -890,894,000USD | -632,261,000USD |
| Good Will | 1,566,700,000USD | 1,566,600,000USD | 2,023,700,000USD | 2,876,500,000USD | 7,904,863,000USD | 6,252,636,000USD | 1,328,045,000USD | 1,282,919,000USD |
| Cash | 329,200,000USD | 295,200,000USD | 370,700,000USD | 348,800,000USD | 587,613,000USD | 257,730,000USD | 76,130,000USD | 25,575,000USD |
| Cash And Short Term Investments | 329,200,000USD | 295,200,000USD | 370,700,000USD | 348,800,000USD | 587,613,000USD | 257,730,000USD | 76,130,000USD | 25,575,000USD |
| Total Current Assets | 1,310,000,000USD | 1,244,600,000USD | 1,462,200,000USD | 1,395,200,000USD | 1,637,238,000USD | 1,328,005,000USD | 493,076,000USD | 408,612,000USD |
| Total Current Liabilities | 1,568,800,000USD | 1,433,500,000USD | 1,600,000,000USD | 1,559,800,000USD | 1,901,974,000USD | 1,569,767,000USD | 650,998,000USD | 643,714,000USD |
| Current Deferred Revenue | 941,400,000USD | 943,900,000USD | 983,100,000USD | 947,500,000USD | 1,030,398,999USD | 707,318,000USD | 407,325,000USD | 391,102,000USD |
| Net Debt | 4,150,100,000USD | 4,297,300,000USD | 4,438,000,000USD | 4,755,800,000USD | 5,025,376,000USD | 3,228,770,000USD | 1,647,800,000USD | 1,964,947,000USD |
| Short Term Debt | 119,900,000USD | 42,500,000USD | 24,400,000USD | 26,700,000USD | 62,754,000USD | 35,455,000USD | 31,130,000USD | 60,345,000USD |
| Short Long Term Debt | 101,500,000USD | 1,300,000USD | — | 1,000,000USD | 30,577,000USD | 28,600,000USD | 9,000,000USD | 60,345,000USD |
| Short Long Term Debt Total | 4,479,300,000USD | 4,592,500,000USD | 4,808,700,000USD | 5,104,600,000USD | 5,612,989,000USD | 3,493,355,000USD | 1,723,930,000USD | 1,990,522,000USD |
| Long Term Debt | 4,321,500,000USD | 4,518,700,000USD | 4,721,100,000USD | 5,005,000,000USD | 3,457,900,000USD | 3,457,900,000USD | 1,628,611,000USD | 1,930,177,000USD |
| Net Receivables | 821,700,000USD | 798,300,000USD | 908,300,000USD | 872,100,000USD | 906,428,000USD | 751,446,000USD | 333,858,000USD | 331,295,000USD |
| Accounts Payable | 150,600,000USD | 124,500,000USD | 144,100,000USD | 101,400,000USD | 129,217,999USD | 798,394,000USD | 26,458,000USD | 38,418,000USD |
| Property Plant Equipment Net | 99,300,000USD | 107,100,000USD | 106,800,000USD | 113,400,000USD | 169,876,000USD | 168,623,000USD | 103,490,000USD | 20,641,000USD |
| Property Plant Equipment Gross | 199,700,000USD | 196,300,000USD | 180,400,000USD | 113,400,000USD | 169,876,000USD | 36,267,000USD | 103,490,000USD | 20,641,000USD |
| Accumulated Other Comprehensive Income | -453,100,000USD | -526,300,000USD | -495,300,000USD | -665,900,000USD | 326,755,000USD | 503,521,000USD | -4,879,000USD | 5,358,000USD |
| Common Stock Shares Outstanding | 673,300,000shares | 693,600,000shares | 671,600,000shares | 678,600,000shares | 640,774,100shares | 273,883,342shares | 273,883,342shares | 305,250,000shares |
| Non Current Assets Total | 9,759,400,000USD | 10,245,600,000USD | 11,244,599,999USD | 12,549,700,000USD | 18,545,741,000USD | 13,659,253,000USD | 3,298,295,000USD | 3,301,062,000USD |
| Non Current Liabilities Total | 4,657,700,000USD | 4,917,700,000USD | 5,114,500,000USD | 5,572,600,000USD | 6,355,136,000USD | 137,721,000USD | 1,891,774,000USD | 2,015,353,000USD |
| Non Current Liabilities Other | 86,200,000USD | 55,900,000USD | 41,900,000USD | 251,500,000USD | 49,445,000USD | 213,445,000USD | 18,891,000USD | 24,838,000USD |
| Non Currrent Assets Other | 66,300,000USD | 67,500,000USD | 43,099,999USD | 50,700,000USD | 48,753,000USD | 216,567,000USD | 18,632,000USD | 26,556,000USD |
| Net Working Capital | -258,800,000USD | -188,900,000USD | -137,800,000USD | -164,600,000USD | -264,736,000USD | -241,762,000USD | -157,922,000USD | -235,102,000USD |
| Unclassified Current Liabilities | -101,500,000USD | — | — | — | — | -742,773,000USD | — | -60,345,000USD |
| Unclassified Non Current Liabilities | 250,000,000USD | 343,100,000USD | 351,500,000USD | -494,700,000USD | 1,675,894,000USD | -4,367,267,000USD | 36,456,000USD | -34,331,000USD |
| Unclassified Equity | -12,810,600,000USD | -12,978,800,000USD | -11,740,500,000USD | -11,744,700,000USD | -11,844,871,000USD | -10,049,317,000USD | -2,208,529,000USD | 1,677,478,000USD |
| Other Assets | — | — | 1USD | 122,100,000USD | 78,648,000USD | 77,730,000USD | 38,120,000USD | 38,982,000USD |
| Short Term Investments | — | — | 2,300,000USD | 2,300,000USD | — | — | — | — |
| Inventory | — | — | 97,400,000USD | 97,400,000USD | 97,400,000USD | 70,048,000USD | 70,048,000USD | 31,030,000USD |
| Unclassified Current Assets | — | — | -99,700,000USD | — | -97,400,000USD | -70,048,000USD | -70,048,000USD | -31,030,000USD |
| Deferred Long Term Liab | — | — | — | 316,100,000USD | 366,996,000USD | 362,261,000USD | 11,620,000USD | 9,493,000USD |
| Other Liab | — | — | — | 494,700,000USD | 804,901,000USD | 471,382,000USD | 196,196,000USD | 85,176,000USD |
| Net Tangible Assets | — | — | — | 5,419,900,000USD | -4,378,524,000USD | -4,029,015,000USD | -1,908,086,000USD | -2,190,832,000USD |
| Unclassified Non Current Assets | — | — | — | — | — | -426,653,000USD | — | — |
| Long Term Investments | — | — | — | — | — | — | 3,644,000USD | 3,644,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow Quarterly
| Metric | Q1 20262026-03-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD | Q2 20242024-06-30 · USD | Q1 20242024-03-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Net Income | -40,200,000USD | -28,300,000USD | -72,000,000USD | -103,900,000USD | -191,800,000USD | -65,600,000USD | -304,300,000USD | -75,000,000USD |
| Depreciation | 184,000,000USD | 191,800,000USD | 190,900,000USD | 185,400,000USD | 186,000,000USD | 177,200,000USD | 187,600,000USD | 184,100,000USD |
| Stock Based Compensation | 14,200,000USD | 16,100,000USD | 18,600,000USD | 10,700,000USD | 11,000,000USD | 15,000,000USD | 18,900,000USD | 15,400,000USD |
| Other Non Cash Items | -13,500,000USD | -14,500,000USD | 31,200,000USD | 24,500,000USD | 138,400,000USD | 38,200,000USD | 215,400,000USD | 3,300,000USD |
| Change To Account Receivables | -62,300,000USD | 4,000,000USD | 35,800,000USD | -33,600,000USD | -55,600,000USD | 45,000,000USD | 28,400,000USD | 74,800,000USD |
| Change In Working Capital | -9,800,000USD | 22,200,000USD | -47,000,000USD | 54,500,000USD | -52,300,000USD | 42,300,000USD | 8,600,000USD | 48,400,000USD |
| Total Cash From Operating Activities | 134,700,000USD | 181,100,000USD | 116,300,000USD | 171,200,000USD | 141,300,000USD | 202,900,000USD | 126,200,000USD | 176,200,000USD |
| Capital Expenditures | -55,800,000USD | -65,600,000USD | -66,000,000USD | -60,900,000USD | -82,200,000USD | -76,600,000USD | -65,900,000USD | -64,400,000USD |
| Free Cash Flow | 78,900,000USD | 115,500,000USD | 50,300,000USD | 110,300,000USD | 59,100,000USD | 126,300,000USD | 60,300,000USD | 111,799,999USD |
| Total Cashflows From Investing Activities | -55,800,000USD | -65,600,000USD | -66,000,000USD | -60,900,000USD | 21,400,000USD | -91,500,000USD | -102,200,000USD | -64,400,000USD |
| Net Borrowings | -138,500,000USD | -100,000,000USD | 0USD | 0USD | -139,300,000USD | -5,400,000USD | — | — |
| Total Cash From Financing Activities | -162,300,000USD | -154,700,000USD | -53,900,000USD | -56,600,000USD | -239,600,000USD | -109,700,000USD | -25,600,000USD | -95,200,000USD |
| Sale Purchase Of Stock | -18,100,000USD | -50,000,000USD | -49,500,000USD | -50,000,000USD | -100,000,000USD | -100,000,000USD | -1,300,000USD | -8,600,000USD |
| Change In Cash | -87,000,000USD | -43,900,000USD | 8,600,000USD | 58,800,000USD | -93,300,000USD | 12,100,000USD | -4,600,000USD | 10,300,000USD |
| Begin Period Cash Flow | 329,200,000USD | 362,600,000USD | 354,000,000USD | 295,200,000USD | 388,500,000USD | 376,400,000USD | 381,000,000USD | 370,700,000USD |
| End Period Cash Flow | 242,200,000USD | 318,700,000USD | 362,600,000USD | 354,000,000USD | 295,200,000USD | 388,500,000USD | 376,400,000USD | 381,000,000USD |
| Other Cashflows From Financing Activities | -5,700,000USD | -3,700,000USD | 4,100,000USD | -6,600,000USD | -300,000USD | -4,000,000USD | -200,000USD | -20,300,000USD |
| Investments | — | -65,600,000USD | -66,000,000USD | -60,900,000USD | 21,400,000USD | -91,500,000USD | -102,200,000USD | -64,400,000USD |
| Dividends Paid | — | 0USD | 0USD | 0USD | 0USD | 0USD | -18,800,000USD | -18,900,000USD |
| Unclassified Operating Cash Flow | — | -6,200,000USD | -5,400,000USD | — | 50,000,000USD | -4,200,000USD | — | — |
| Unclassified Investing Cash Flow | — | 65,600,000USD | 66,000,000USD | 60,900,000USD | 82,200,000USD | 95,800,000USD | 85,100,000USD | 64,400,000USD |
| Unclassified Financing Cash Flow | — | — | -8,500,000USD | — | — | — | -5,300,000USD | -47,400,000USD |
| Other Cashflows From Investing Activities | — | — | — | — | — | -19,200,000USD | -19,200,000USD | — |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD | FY 20182018-12-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Net Income | -201,100,000USD | -636,700,000USD | -911,200,000USD | -3,960,200,000USD | -3,960,200,000USD | -270,448,000USD | -258,632,999USD | -242,162,000USD |
| Depreciation | 757,200,000USD | 727,000,000USD | 708,300,000USD | 710,500,000USD | 710,500,000USD | 537,815,000USD | 200,542,000USD | 237,225,000USD |
| Stock Based Compensation | 63,100,000USD | 59,900,000USD | 109,000,000USD | 93,900,000USD | 93,900,000USD | 33,329,000USD | 51,383,000USD | 13,715,000USD |
| Other Non Cash Items | 47,300,000USD | 500,100,000USD | 976,900,000USD | 3,991,300,000USD | 3,991,300,000USD | -31,650,000USD | 120,216,000USD | -27,394,000USD |
| Change To Account Receivables | -5,000,000USD | 92,600,000USD | -25,500,000USD | -28,300,000USD | -28,300,000USD | -64,067,000USD | -593,000USD | -50,906,000USD |
| Change In Working Capital | 3,500,000USD | -24,900,000USD | -60,400,000USD | -271,900,000USD | -271,900,000USD | 68,079,000USD | 3,715,000USD | -27,200,000USD |
| Total Cash From Operating Activities | 628,500,000USD | 646,600,000USD | 744,200,000USD | 509,300,000USD | 509,300,000USD | 323,767,000USD | 117,580,000USD | -26,100,000USD |
| Capital Expenditures | -263,200,000USD | -289,100,000USD | -242,500,000USD | -202,900,000USD | -202,900,000USD | -118,543,000USD | -69,836,000USD | -45,410,000USD |
| Free Cash Flow | 365,300,000USD | 357,500,000USD | 501,700,000USD | 306,400,000USD | 306,400,000USD | 205,224,000USD | 47,744,000USD | -71,510,000USD |
| Total Cashflows From Investing Activities | -263,200,000USD | -236,700,000USD | -237,400,000USD | 57,300,000USD | -2,988,768,000USD | -2,992,168,000USD | -140,885,000USD | 11,934,000USD |
| Net Borrowings | -100,000,000USD | -198,100,000USD | -300,000,000USD | -498,600,000USD | -115,940,000USD | -115,940,000USD | 978,491,000USD | -31,709,000USD |
| Total Cash From Financing Activities | -343,100,000USD | -470,100,000USD | -496,500,000USD | -759,200,000USD | -759,200,000USD | 4,032,160,000USD | 75,215,000USD | -32,605,000USD |
| Dividends Paid | 0USD | -37,700,000USD | -75,500,000USD | -75,400,000USD | -75,400,000USD | -18,868,000USD | -18,868,000USD | -18,868,000USD |
| Sale Purchase Of Stock | -224,500,000USD | -200,000,000USD | -100,000,000USD | -175,000,000USD | -175,000,000USD | -159,356,000USD | 1,582,000USD | 1,574,000USD |
| Change In Cash | 34,000,000USD | -75,500,000USD | 13,900,000USD | -230,800,000USD | -230,800,000USD | 315,205,000USD | 50,555,000USD | -51,964,000USD |
| Begin Period Cash Flow | 295,200,000USD | 370,700,000USD | 356,800,000USD | 587,600,000USD | 587,600,000USD | 272,408,000USD | 25,584,000USD | 77,548,000USD |
| End Period Cash Flow | 329,200,000USD | 295,200,000USD | 370,700,000USD | 356,800,000USD | 356,800,000USD | 587,613,000USD | 76,139,000USD | 25,584,000USD |
| Other Cashflows From Investing Activities | -263,200,000USD | 84,400,000USD | 285,000,000USD | 260,200,000USD | -2,881,055,000USD | -2,884,455,000USD | -2,625,000USD | 80,883,000USD |
| Other Cashflows From Financing Activities | -9,200,000USD | -34,300,000USD | -20,000,000USD | -16,100,000USD | -16,100,000USD | 3,528,662,000USD | 479,716,000USD | -896,000USD |
| Unclassified Operating Cash Flow | -41,500,000USD | 21,200,000USD | -78,400,000USD | -54,300,000USD | -54,300,000USD | -13,358,000USD | — | 19,716,000USD |
| Unclassified Investing Cash Flow | 263,200,000USD | 204,700,000USD | -337,600,000USD | -57,300,000USD | 4,139,647,000USD | 3,002,998,000USD | 72,461,000USD | -35,473,000USD |
| Unclassified Financing Cash Flow | -9,400,000USD | — | — | — | -376,760,000USD | 797,662,000USD | -1,365,706,000USD | 17,294,000USD |
| Investments | — | -236,700,000USD | 57,700,000USD | 57,300,000USD | -4,044,460,000USD | -2,992,168,000USD | -140,885,000USD | 11,934,000USD |
| Change To Inventory | — | — | -210,300,000USD | -210,300,000USD | 100,746,000USD | 100,746,000USD | -26,829,000USD | 8,258,000USD |
| Issuance Of Capital Stock | — | — | 3,500,000USD | 5,700,000USD | 2,260,520,000USD | 843,744,000USD | — | 1,574,000USD |
| Change To Liabilities | — | — | — | -162,200,000USD | -54,075,000USD | -90,961,000USD | 19,642,000USD | 15,448,000USD |
| Cash And Cash Equivalents Changes | — | — | — | -192,600,000USD | 201,312,000USD | 197,912,000USD | — | — |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Operating metrics
No operating metrics are currently published for this company.
Revenue breakdown
| Period | Dimension | Business / region | Revenue | Currency | Source |
|---|---|---|---|---|---|
| Q2 2026Quarterly · 2026-06-30 | Product | Re Occurring Revenues | 109,300,000 | USD | Disclosure |
| Q2 2026Quarterly · 2026-06-30 | Product | Subscription Revenues | 403,300,000 | USD | Disclosure |
| Q2 2026Quarterly · 2026-06-30 | Product | Transactional Revenues | 74,700,000 | USD | Disclosure |
| Q2 2026Quarterly · 2026-06-30 | Segment | Academia Government Group | 300,300,000 | USD | Disclosure |
| Q2 2026Quarterly · 2026-06-30 | Segment | Intellectual Property Group | 198,300,000 | USD | Disclosure |
| Q2 2026Quarterly · 2026-06-30 | Segment | Life Sciences And Healthcare Group | 88,700,000 | USD | Disclosure |
| Q1 2026Quarterly · 2026-03-31 | Product | Re Occurring Revenues | 108,600,000 | USD | 0001764046-26-000058 |
| Q1 2026Quarterly · 2026-03-31 | Product | Subscription Revenues | 397,500,000 | USD | 0001764046-26-000058 |
| Q1 2026Quarterly · 2026-03-31 | Product | Transactional Revenues | 79,400,000 | USD | 0001764046-26-000058 |
| Q1 2026Quarterly · 2026-03-31 | Segment | Academia Government Group | 295,000,000 | USD | 0001764046-26-000058 |
| Q1 2026Quarterly · 2026-03-31 | Segment | Intellectual Property Group | 197,200,000 | USD | 0001764046-26-000058 |
| Q1 2026Quarterly · 2026-03-31 | Segment | Life Sciences And Healthcare Group | 93,300,000 | USD | 0001764046-26-000058 |
| Q4 2025Quarterly · 2025-12-31 | Product | Re Occurring Revenues | 114,100,000 | USD | Legacy provider |
| Q4 2025Quarterly · 2025-12-31 | Product | Subscription Revenues | 405,800,000 | USD | Legacy provider |
| Q4 2025Quarterly · 2025-12-31 | Product | Transactional Revenues | 97,100,000 | USD | Legacy provider |
| Q4 2025Quarterly · 2025-12-31 | Segment | Academia Government Group | 312,300,000 | USD | Legacy provider |
| Q4 2025Quarterly · 2025-12-31 | Segment | Intellectual Property Group | 206,400,000 | USD | Legacy provider |
| Q4 2025Quarterly · 2025-12-31 | Segment | Life Sciences And Healthcare Group | 98,300,000 | USD | Legacy provider |
| FY 2025Yearly · 2025-12-31 | Geography | Asia Pacific | 497,400,000 | USD | 0001764046-26-000019 |
| FY 2025Yearly · 2025-12-31 | Geography | EMEA | 654,800,000 | USD | 0001764046-26-000019 |
| FY 2025Yearly · 2025-12-31 | Geography | North America | 1,303,000,000 | USD | 0001764046-26-000019 |
| FY 2025Yearly · 2025-12-31 | Product | Re Occurring Revenues | 434,200,000 | USD | 0001764046-26-000019 |
| FY 2025Yearly · 2025-12-31 | Product | Subscription Revenues | 1,605,500,000 | USD | 0001764046-26-000019 |
| FY 2025Yearly · 2025-12-31 | Product | Transactional Revenues | 415,500,000 | USD | 0001764046-26-000019 |
| FY 2025Yearly · 2025-12-31 | Segment | Academia Government Group | 1,266,000,000 | USD | 0001764046-26-000019 |
| FY 2025Yearly · 2025-12-31 | Segment | Intellectual Property Group | 799,400,000 | USD | 0001764046-26-000019 |
| FY 2025Yearly · 2025-12-31 | Segment | Life Sciences And Healthcare Group | 389,800,000 | USD | 0001764046-26-000019 |
| Q3 2025Quarterly · 2025-09-30 | Product | Re Occurring Revenues | 105,300,000 | USD | 0001764046-25-000116 |
| Q3 2025Quarterly · 2025-09-30 | Product | Subscription Revenues | 405,400,000 | USD | 0001764046-25-000116 |
| Q3 2025Quarterly · 2025-09-30 | Product | Transactional Revenues | 112,400,000 | USD | 0001764046-25-000116 |
| Q3 2025Quarterly · 2025-09-30 | Segment | Academia Government Group | 332,500,000 | USD | 0001764046-25-000116 |
| Q3 2025Quarterly · 2025-09-30 | Segment | Intellectual Property Group | 197,800,000 | USD | 0001764046-25-000116 |
| Q3 2025Quarterly · 2025-09-30 | Segment | Life Sciences And Healthcare Group | 92,800,000 | USD | 0001764046-25-000116 |
| Q2 2025Quarterly · 2025-06-30 | Product | Re Occurring Revenues | 108,900,000 | USD | 0001764046-25-000096 |
| Q2 2025Quarterly · 2025-06-30 | Product | Subscription Revenues | 405,700,000 | USD | 0001764046-25-000096 |
| Q2 2025Quarterly · 2025-06-30 | Product | Transactional Revenues | 106,800,000 | USD | 0001764046-25-000096 |
| Q2 2025Quarterly · 2025-06-30 | Segment | Academia Government Group | 318,500,000 | USD | 0001764046-25-000096 |
| Q2 2025Quarterly · 2025-06-30 | Segment | Intellectual Property Group | 202,500,000 | USD | 0001764046-25-000096 |
| Q2 2025Quarterly · 2025-06-30 | Segment | Life Sciences And Healthcare Group | 100,400,000 | USD | 0001764046-25-000096 |
| Q1 2025Quarterly · 2025-03-31 | Product | Re Occurring Revenues | 105,900,000 | USD | 0001764046-26-000058 |
| Q1 2025Quarterly · 2025-03-31 | Product | Subscription Revenues | 388,600,000 | USD | 0001764046-26-000058 |
| Q1 2025Quarterly · 2025-03-31 | Product | Transactional Revenues | 99,200,000 | USD | 0001764046-26-000058 |
| Q1 2025Quarterly · 2025-03-31 | Segment | Academia Government Group | 302,700,000 | USD | 0001764046-26-000058 |
| Q1 2025Quarterly · 2025-03-31 | Segment | Intellectual Property Group | 192,700,000 | USD | 0001764046-26-000058 |
| Q1 2025Quarterly · 2025-03-31 | Segment | Life Sciences And Healthcare Group | 98,300,000 | USD | 0001764046-26-000058 |
| Q4 2024Quarterly · 2024-12-31 | Product | Re Occurring Revenues | 112,000,000 | USD | Legacy provider |
| Q4 2024Quarterly · 2024-12-31 | Product | Subscription Revenues | 407,000,000 | USD | Legacy provider |
| Q4 2024Quarterly · 2024-12-31 | Product | Transactional Revenues | 144,000,000 | USD | Legacy provider |
| Q4 2024Quarterly · 2024-12-31 | Segment | Academia Government Group | 342,900,000 | USD | Legacy provider |
| Q4 2024Quarterly · 2024-12-31 | Segment | Intellectual Property Group | 209,100,000 | USD | Legacy provider |
| Q4 2024Quarterly · 2024-12-31 | Segment | Life Sciences And Healthcare Group | 111,000,000 | USD | Legacy provider |
| FY 2024Yearly · 2024-12-31 | Geography | Asia Pacific | 507,500,000 | USD | 0001764046-26-000019 |
| FY 2024Yearly · 2024-12-31 | Geography | EMEA | 667,800,000 | USD | 0001764046-26-000019 |
| FY 2024Yearly · 2024-12-31 | Geography | North America | 1,381,400,000 | USD | 0001764046-26-000019 |
| FY 2024Yearly · 2024-12-31 | Product | Re Occurring Revenues | 429,800,000 | USD | 0001764046-26-000019 |
| FY 2024Yearly · 2024-12-31 | Product | Subscription Revenues | 1,626,800,000 | USD | 0001764046-26-000019 |
| FY 2024Yearly · 2024-12-31 | Product | Transactional Revenues | 500,100,000 | USD | 0001764046-26-000019 |
| FY 2024Yearly · 2024-12-31 | Segment | Academia Government Group | 1,326,400,000 | USD | 0001764046-26-000019 |
| FY 2024Yearly · 2024-12-31 | Segment | Intellectual Property Group | 811,400,000 | USD | 0001764046-26-000019 |
| FY 2024Yearly · 2024-12-31 | Segment | Life Sciences And Healthcare Group | 418,900,000 | USD | 0001764046-26-000019 |
| Q3 2024Quarterly · 2024-09-30 | Product | Re Occurring Revenues | 106,700,000 | USD | 0001764046-25-000116 |
| Q3 2024Quarterly · 2024-09-30 | Product | Subscription Revenues | 411,100,000 | USD | 0001764046-25-000116 |
| Q3 2024Quarterly · 2024-09-30 | Product | Transactional Revenues | 104,400,000 | USD | 0001764046-25-000116 |
| Q3 2024Quarterly · 2024-09-30 | Segment | Academia Government Group | 321,300,000 | USD | 0001764046-25-000116 |
| Q3 2024Quarterly · 2024-09-30 | Segment | Intellectual Property Group | 199,800,000 | USD | 0001764046-25-000116 |
| Q3 2024Quarterly · 2024-09-30 | Segment | Life Sciences And Healthcare Group | 101,100,000 | USD | 0001764046-25-000116 |
| FY 2023Yearly · 2023-12-31 | Geography | Asia Pacific | 515,800,000 | USD | 0001764046-26-000019 |
| FY 2023Yearly · 2023-12-31 | Geography | EMEA | 707,500,000 | USD | 0001764046-26-000019 |
| FY 2023Yearly · 2023-12-31 | Geography | North America | 1,405,500,000 | USD | 0001764046-26-000019 |
| FY 2023Yearly · 2023-12-31 | Product | Re Occurring Revenues | 444,600,000 | USD | 0001764046-26-000019 |
| FY 2023Yearly · 2023-12-31 | Product | Subscription Revenues | 1,618,100,000 | USD | 0001764046-26-000019 |
| FY 2023Yearly · 2023-12-31 | Product | Transactional Revenues | 566,100,000 | USD | 0001764046-26-000019 |
| FY 2023Yearly · 2023-12-31 | Segment | Academia Government Group | 1,323,300,000 | USD | 0001764046-26-000019 |
| FY 2023Yearly · 2023-12-31 | Segment | Intellectual Property Group | 862,700,000 | USD | 0001764046-26-000019 |
| FY 2023Yearly · 2023-12-31 | Segment | Life Sciences And Healthcare Group | 442,800,000 | USD | 0001764046-26-000019 |
| FY 2022Yearly · 2022-12-31 | Geography | Asia Pacific | 499,200,000 | USD | 0001764046-25-000011 |
| FY 2022Yearly · 2022-12-31 | Geography | EMEA | 698,300,000 | USD | 0001764046-25-000011 |
| FY 2022Yearly · 2022-12-31 | Geography | North America | 1,462,300,000 | USD | 0001764046-25-000011 |
| FY 2022Yearly · 2022-12-31 | Product | Re Occurring Revenues | 441,900,000 | USD | 0001764046-25-000011 |
| FY 2022Yearly · 2022-12-31 | Product | Subscription Revenues | 1,618,800,000 | USD | 0001764046-25-000011 |
| FY 2022Yearly · 2022-12-31 | Product | Transaction Revenues | 599,100,000 | USD | 0001764046-25-000011 |
| FY 2022Yearly · 2022-12-31 | Segment | Academia Government Group | 1,280,100,000 | USD | 0001764046-25-000011 |
| FY 2022Yearly · 2022-12-31 | Segment | Intellectual Property Group | 927,100,000 | USD | 0001764046-25-000011 |
| FY 2022Yearly · 2022-12-31 | Segment | Life Sciences And Healthcare Group | 452,600,000 | USD | 0001764046-25-000011 |
| FY 2021Yearly · 2021-12-31 | Geography | Asia Pacific | 396,400,000 | USD | 0001764046-24-000016 |
| FY 2021Yearly · 2021-12-31 | Geography | EMEA | 555,800,000 | USD | 0001764046-24-000016 |
| FY 2021Yearly · 2021-12-31 | Geography | North America | 924,700,000 | USD | 0001764046-24-000016 |
| FY 2021Yearly · 2021-12-31 | Segment | Academia Government Group | 489,400,000 | USD | 0001764046-24-000016 |
| FY 2021Yearly · 2021-12-31 | Segment | Intellectual Property Group | 974,300,000 | USD | 0001764046-24-000016 |
| FY 2021Yearly · 2021-12-31 | Segment | Life Sciences And Healthcare Group | 413,200,000 | USD | 0001764046-24-000016 |
| FY 2020Yearly · 2020-12-31 | Segment | Academia Government Group | 384,700,000 | USD | 0001764046-23-000012 |
| FY 2020Yearly · 2020-12-31 | Segment | Intellectual Property Group | 517,300,000 | USD | 0001764046-23-000012 |
| FY 2020Yearly · 2020-12-31 | Segment | Life Sciences And Healthcare Group | 352,100,000 | USD | 0001764046-23-000012 |
| FY 2019Yearly · 2019-12-31 | Geography | Asia Pacific | 233,004,000 | USD | 0001764046-22-000064 |
| FY 2019Yearly · 2019-12-31 | Geography | EMEA | 278,738,000 | USD | 0001764046-22-000064 |
| FY 2019Yearly · 2019-12-31 | Geography | North America | 463,041,000 | USD | 0001764046-22-000064 |
| FY 2019Yearly · 2019-12-31 | Segment | Intellectual Property Group | 426,803,000 | USD | 0001764046-22-000064 |
| FY 2019Yearly · 2019-12-31 | Segment | Science Group | 547,542,000 | USD | 0001764046-22-000064 |
| FY 2018Yearly · 2018-12-31 | Geography | Asia Pacific | 221,979,000 | USD | 0001764046-21-000022 |
| FY 2018Yearly · 2018-12-31 | Geography | EMEA | 273,744,000 | USD | 0001764046-21-000022 |
Periods follow company fiscal calendars. Quarterly, annual and year-to-date amounts are shown separately. Missing values are not zero. Data may be delayed, incomplete or corrected; follow the disclosure links to verify figures.